Skip to main content

. 1946 Jul;25(4):528–533. doi: 10.1172/JCI101734

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL

W T Longcope ¹, John A Luetscher Jr ¹, M M Wintrobe ¹, Val Jäger ¹

PMCID: PMC435590 PMID: 16695344

532

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Luetscher J. A., Eagle H., Longcope W. T., Watson E. B. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION. J Clin Invest. 1946 Jul;25(4):534–540. doi: 10.1172/JCI101735. [DOI] [PMC free article] [PubMed] [Google Scholar]
Modell W., Gold H., Cattell M. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN. J Clin Invest. 1946 Jul;25(4):480–487. doi: 10.1172/JCI101731. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sulzberger M. B., Baer R. L., Kanof A. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION. J Clin Invest. 1946 Jul;25(4):474–479. doi: 10.1172/JCI101730. [DOI] [PMC free article] [PubMed] [Google Scholar]
Waters L. L., Stock C. BAL (BRITISH ANTI-LEWISITE). Science. 1945 Dec 14;102(2659):601–606. doi: 10.1126/science.102.2659.601. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES